Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How long can a patient with newly diagnosed merkel cell carcinoma wait for wide local excision with sentinel node biopsy?

6
2 Answers

Mednet Member
Mednet Member
Dermatology · Dermatology & Laser Center

A recent study I read on this same question regarding sentinel node biopsy (SNB) performed after melanoma wide excision found that the sentinel node could still be found just fine. And I have found that in practice a number of times when I wide-excised obvious melanomas at first presentation visit. ...

Would you use SBRT to treat a lipoma of the spine that recurred twice after surgery?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · VA New Jersey Healthcare System - East Orange campus.

Interesting question for an infrequent clinical matter. SBRT for recurring Lipoma of the spine, maybe - in my humble opinion.Related clinical questions -->>:1) Are the lesion(s) becoming more aggressive histologically?2) Are the lesion(s) becoming difficult anatomically for more surgery resections? ...

What are your current recommendations for treatment of symptomatic splenomegaly in the setting of myelofibrosis when splenectomy is not an option?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Wright State University

I use low dose, typically 50cGy per fraction for 4-6 fractions, done in 2 fractions per week; need to check platelets each week during course.

What is your experience with Gelclair for oral mucositis during head & neck radiotherapy?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Henry Ford Health System

I used Gelclair for my patients regularly till a few years ago. However, I did not find a significant difference in the rates of mucositis among those who did and did not use this product. That is my anecdotal experience and I would be curious to hear other thoughts from those who are routinely reco...

How would you treat a patient with a granular cell tumor of the breast with positive margins following excision?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Montefiore-Einstein Medical Center

I would recommend a re-excision to widely negative margins. I would not radiate.

How do you treat SNUC?

3
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

There’s no standard treatment. Suitable for gross total resection: surgery and postop RT and concomitant chemo.Not suitable for GTR: chemo RT or induction chemo and reevaluate for surgery and postop RT chemo.

Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Yes, FAST-Forward is fine after oncoplastic reduction as long as dose homogeneity criteria can be met (V105 < 5%).

What dose and OAR constraints do you use for boost with IMRT or SBRT when a patient with cancer of the cervix is not a candidate for brachytherapy?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · UAB Department of Radiation Oncology

Concurrent chemoradiotherapy plus brachytherapy boost (intracavitary or interstitial) is the standard of care in patients with locally advanced cervical cancer. In light of published data suggesting inferior survival if brachytherapy is omitted from definitive treatment, we do not recommend utilizin...

For locally advanced adenocarcinoma of the maxillary sinus, how should the neck be managed?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

ENI if high grade

Would you add a brachytheray boost to a locally advanced cervical cancer after surgical resection and pelvic RT?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Radiation Oncology And Cyberknife Treatment Ctr

In general, a brachytherapy boost following external radiation is not standard when treating women for locally advanced cervical cancer post hysterectomy. Neither of the 2 major adjuvant GOG trials (92 and 109) allowed a brachytherapy boost, and even the currently open GOG trial, GOG 263, does not i...